Dengue IgG/IgM Rapid Test Device

Call For Pricing.

Model Number: NH-65282

Brand: Niche Healthcare

The Dengue IgG/IgM Rapid Test Device( Whole Blood/Serum/Plasma )is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to dengue virus in human whole blood, serum or plasma specimens. It provides an aid in the diagnosis of infection with Dengue viruses.



Catalog No. DEN-4022 Format Device
Specimen Whole Blood/Serum/Plasma Certificate CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Test device, dropper, desiccant, buffer and instruction for use


The Dengue IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Identification of Dengue Virus Exposure: The rapid test detects IgG and IgM antibodies against the Dengue virus in whole blood, serum, or plasma, helping identify individuals who have been exposed to the virus.

  2. Early Diagnosis of Dengue Infection: IgM antibodies are typically produced early in the course of Dengue infection, allowing for early diagnosis. Detection of IgG antibodies indicates past exposure, aiding in differentiating acute from past infections.

  3. Differentiation of Dengue from Other Febrile Illnesses: IgM and IgG detection aids in distinguishing Dengue infection from other febrile illnesses, contributing to accurate diagnosis and appropriate treatment.

  4. Assessment of Immune Response: Monitoring IgG and IgM levels helps assess the immune response to Dengue virus exposure. Rising IgM levels may indicate acute infection, while the presence of IgG suggests previous exposure and potential immunity.

  5. Patient Management: Results from the test can guide healthcare providers in managing Dengue cases, including appropriate supportive care and monitoring for complications.

  6. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage Dengue cases more effectively.

  7. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making, allowing for immediate patient management.

  8. Public Health Surveillance: Monitoring IgG/IgM antibody levels in the population through rapid testing contributes to public health surveillance efforts. This information helps in planning and implementing preventive measures, especially during outbreaks.

  9. Travel Medicine: Rapid testing can be valuable for travelers returning from regions where Dengue is endemic, aiding in the early diagnosis of the infection and guiding appropriate medical care.

  10. Reduced Hospitalizations: Early detection and appropriate management based on IgG/IgM results may contribute to minimizing the severity of Dengue infection, potentially reducing the need for hospitalizations.


Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.


Types of Infections

Types of Infections


For more information, contact us 01274 965089 or check out our website at

Further clinical information can be found on our blog page:

For products not found on our online website, please view our Healthcare catalogues:

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at 


There are no reviews yet.

Be the first to review “Dengue IgG/IgM Rapid Test Device”